240 related articles for article (PubMed ID: 11391787)
1. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
Song J; Markley JL
J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
[TBL] [Abstract][Full Text] [Related]
2. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
[TBL] [Abstract][Full Text] [Related]
3. Assignment of the 13C-NMR spectra of virgin and reactive-site modified turkey ovomucoid third domain.
Robertson AD; Rhyu GI; Westler WM; Markley JL
Biopolymers; 1990 Feb; 29(2):461-7. PubMed ID: 2331509
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
5. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
Huang K; Lu W; Anderson S; Laskowski M; James MN
Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
[TBL] [Abstract][Full Text] [Related]
6. Structure of the subtilisin Carlsberg-OMTKY3 complex reveals two different ovomucoid conformations.
Maynes JT; Cherney MM; Qasim MA; Laskowski M; James MN
Acta Crystallogr D Biol Crystallogr; 2005 May; 61(Pt 5):580-8. PubMed ID: 15858268
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods.
Walkenhorst WF; Krezel AM; Rhyu GI; Markley JL
J Mol Biol; 1994 Sep; 242(3):215-30. PubMed ID: 8089843
[TBL] [Abstract][Full Text] [Related]
8. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
Krystek S; Stouch T; Novotny J
J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
[TBL] [Abstract][Full Text] [Related]
9. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
Song J; Laskowski M; Qasim MA; Markley JL
Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
[TBL] [Abstract][Full Text] [Related]
10. Two-dimensional NMR studies of Kazal proteinase inhibitors. 2. Sequence-specific assignments and secondary structure of reactive site modified turkey ovomucoid third domain.
Rhyu GI; Markley JL
Biochemistry; 1988 Apr; 27(7):2529-39. PubMed ID: 3382637
[TBL] [Abstract][Full Text] [Related]
11. Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution.
Fujinaga M; Sielecki AR; Read RJ; Ardelt W; Laskowski M; James MN
J Mol Biol; 1987 May; 195(2):397-418. PubMed ID: 3477645
[TBL] [Abstract][Full Text] [Related]
12. Probing intermolecular main chain hydrogen bonding in serine proteinase-protein inhibitor complexes: chemical synthesis of backbone-engineered turkey ovomucoid third domain.
Lu W; Qasim MA; Laskowski M; Kent SB
Biochemistry; 1997 Jan; 36(4):673-9. PubMed ID: 9020764
[TBL] [Abstract][Full Text] [Related]
13. Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
Bigler TL; Lu W; Park SJ; Tashiro M; Wieczorek M; Wynn R; Laskowski M
Protein Sci; 1993 May; 2(5):786-99. PubMed ID: 8495199
[TBL] [Abstract][Full Text] [Related]
14. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
[TBL] [Abstract][Full Text] [Related]
15. Protein inhibitors of serine proteinases: role of backbone structure and dynamics in controlling the hydrolysis constant.
Song J; Markley JL
Biochemistry; 2003 May; 42(18):5186-94. PubMed ID: 12731859
[TBL] [Abstract][Full Text] [Related]
16. The thermodynamics of protein-protein recognition as characterized by a combination of volumetric and calorimetric techniques: the binding of turkey ovomucoid third domain to alpha-chymotrypsin.
Filfil R; Chalikian TV
J Mol Biol; 2003 Feb; 326(4):1271-88. PubMed ID: 12589768
[TBL] [Abstract][Full Text] [Related]
17. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
[TBL] [Abstract][Full Text] [Related]
18. NMR studies of internal dynamics of serine proteinase protein inhibitors: Binding region mobilities of intact and reactive-site hydrolyzed Cucurbita maxima trypsin inhibitor (CMTI)-III of the squash family and comparison with those of counterparts of CMTI-V of the potato I family.
Liu J; Gong Y; Prakash O; Wen L; Lee I; Huang JK; Krishnamoorthi R
Protein Sci; 1998 Jan; 7(1):132-41. PubMed ID: 9514268
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the non-additivity effects in the sequence-to-reactivity algorithm for serine peptidases and their inhibitors.
Lee TW; Qasim MA; Laskowski M; James MN
J Mol Biol; 2007 Mar; 367(2):527-46. PubMed ID: 17266986
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
